This success story displays positive outcomes of PATH's work in the Democratic Republic of Congo related to the control and treatment of multidrug-resistant tuberculosis (MDR-TB), achieved by introducing the innovative GeneXpert diagnostic machine. This work was made possible with funding from the United States Agency for International Development.